People 65 years and older and those who are moderately or severely immunocompromised should receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose. See the CDC's updated guidance. More Info
Results are submitted for each rapid, point-of-care antigen test performed for COVID-19 to the Division of Public Health (DPH) within 24 hours by a dedicated and HIPAA-compliant web-based DPH portal.